Stocks and Investing Stocks and Investing
Wed, April 15, 2020
Tue, April 14, 2020

Christopher Marai Maintained (ALNY) at Sell and Held Target at $74 on, Apr 14th, 2020


Published on 2024-10-27 02:55:06 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Sell and Held Target at $74 on, Apr 14th, 2020.

Christopher has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Friday, February 7th, 2020
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $190 on, Thursday, December 19th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
Contributing Sources